Kryza T - Search Results

1

Engineering osteoblastic metastases to delineate the adaptive response of androgen-deprived prostate cancer in the bone metastatic microenvironment.

Bock N, Shokoohmand A, Kryza T, Röhl J, Meijer J, Tran PA, Nelson CC, Clements JA, Hutmacher DW. Bock N, et al. Among authors: kryza t. Bone Res. 2019 Apr 25;7:13. doi: 10.1038/s41413-019-0049-8. eCollection 2019. Bone Res. 2019. PMID: 31044095 Free PMC article.

2

The kallikrein-related peptidase family: Dysregulation and functions during cancer progression.

Kryza T, Silva ML, Loessner D, Heuzé-Vourc'h N, Clements JA. Kryza T, et al. Biochimie. 2016 Mar;122:283-99. doi: 10.1016/j.biochi.2015.09.002. Epub 2015 Sep 4. Biochimie. 2016. PMID: 26343558 Review.

3

Kryza T, Silva LM, Bock N, Fuhrman-Luck RA, Stephens CR, Gao J, Samaratunga H; Australian Prostate Cancer BioResource; Lawrence MG, Hooper JD, Dong Y, Risbridger GP, Clements JA. Kryza T, et al. Mol Oncol. 2017 Oct;11(10):1307-1329. doi: 10.1002/1878-0261.12075. Epub 2017 Aug 10. Mol Oncol. 2017. PMID: 28510269 Free PMC article.

4

Mass spectrometry-based determination of Kallikrein-related peptidase 7 (KLK7) cleavage preferences and subsite dependency.

Silva LM, Stoll T, Kryza T, Stephens CR, Hastie ML, Irving-Rodgers HF, Dong Y, Gorman JJ, Clements JA. Silva LM, et al. Among authors: kryza t. Sci Rep. 2017 Jul 28;7(1):6789. doi: 10.1038/s41598-017-06680-4. Sci Rep. 2017. PMID: 28754951 Free PMC article.

5

Post-GWAS in prostate cancer: from genetic association to biological contribution.

Farashi S, Kryza T, Clements J, Batra J. Farashi S, et al. Among authors: kryza t. Nat Rev Cancer. 2019 Jan;19(1):46-59. doi: 10.1038/s41568-018-0087-3. Nat Rev Cancer. 2019. PMID: 30538273 Review.

6

Integration of Two In-depth Quantitative Proteomics Approaches Determines the Kallikrein-related Peptidase 7 (KLK7) Degradome in Ovarian Cancer Cell Secretome.

Silva LM, Kryza T, Stoll T, Hoogland C, Dong Y, Stephens CR, Hastie ML, Magdolen V, Kleifeld O, Gorman JJ, Clements JA. Silva LM, et al. Among authors: kryza t. Mol Cell Proteomics. 2019 May;18(5):818-836. doi: 10.1074/mcp.RA118.001304. Epub 2019 Jan 31. Mol Cell Proteomics. 2019. PMID: 30705123 Free PMC article.

7

The molecular function of kallikrein-related peptidase 14 demonstrates a key modulatory role in advanced prostate cancer.

Kryza T, Bock N, Lovell S, Rockstroh A, Lehman ML, Lesner A, Panchadsaram J, Silva LM, Srinivasan S, Snell CE, Williams ED, Fazli L, Gleave M, Batra J, Nelson C, Tate EW, Harris J, Hooper JD, Clements JA. Kryza T, et al. Mol Oncol. 2020 Jan;14(1):105-128. doi: 10.1002/1878-0261.12587. Epub 2019 Nov 28. Mol Oncol. 2020. PMID: 31630475 Free PMC article.

8

KLK4 Induces Anti-Tumor Effects in Human Xenograft Mouse Models of Orthotopic and Metastatic Prostate Cancer.

Tse BW, Kryza T, Yeh MC, Dong Y, Sokolowski KA, Walpole C, Dreyer T, Felber J, Harris J, Magdolen V, Russell PJ, Clements JA. Tse BW, et al. Among authors: kryza t. Cancers (Basel). 2020 Nov 24;12(12):3501. doi: 10.3390/cancers12123501. Cancers (Basel). 2020. PMID: 33255452 Free PMC article.

9

[No title available]

[No authors listed] [No authors listed] PMID: 33451784

10

A Suite of Activity-Based Probes To Dissect the KLK Activome in Drug-Resistant Prostate Cancer.

Lovell S, Zhang L, Kryza T, Neodo A, Bock N, De Vita E, Williams ED, Engelsberger E, Xu C, Bakker AT, Maneiro M, Tanaka RJ, Bevan CL, Clements JA, Tate EW. Lovell S, et al. Among authors: kryza t. J Am Chem Soc. 2021 Jun 16;143(23):8911-8924. doi: 10.1021/jacs.1c03950. Epub 2021 Jun 4. J Am Chem Soc. 2021. PMID: 34085829 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters